SynthesisMedicine2020
Cost-effectiveness and diagnostic accuracy of telemedicine in macular disease and diabetic retinopathy: A systematic review and meta-analysis.
Synthesis in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 42 citations in OpenAlex.
- Telemedicine for diabetic retinopathy screening.The Cochrane database of systematic reviews · 2026Article
- Optimizing Diabetic Retinopathy Screening at Primary Health Centres in India: A Cost-Effectiveness Analysis.PharmacoEconomics - open · 2025Article
- Diabetic macular edema (DME): dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights.International journal of retina and vitreous · 2024Review
- Implementing teleophthalmology services to improve cost-effectiveness of the national eye care system.Eye (London, England) · 2024Article
- Enhancing diabetic retinopathy screening: Non-mydriatic fundus photography-assisted telemedicine for improved clinical management.World journal of diabetes · 2024Article
- Teleophthalmology at a primary and tertiary eye care network from India: environmental and economic impact.Eye (London, England) · 2024Article
- Retinal detachment.Nature reviews. Disease primers · 2024Review
- Evaluation of Sensitivity and Specificity of Acuity 360 Telemedicine Vision Screening System.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Factors Associated with Utilization of Teleretinal Imaging in a Hospital-Based Primary Care Setting.Vision (Basel, Switzerland) · 2023Article
- Examining the Role of Telemedicine in Diabetic Retinopathy.Journal of clinical medicine · 2023Review
- Comparable quality performance between telemedicine and office-based care for abnormal BMI screening and management.Obesity science & practice · 2023Article
- Knowledge, attitude and perception of optometrists in Trinidad and Tobago towards teleoptometry.Heliyon · 2023Article
- Detection of trachoma using machine learning approaches.PLoS neglected tropical diseases · 2022Article
- Knowledge, Attitudes, and Perceptions of Jordanians Toward Adopting and Using Telemedicine: National Cross-sectional Study.JMIR human factors · 2022Article
- Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.The Lancet regional health. Western Pacific · 2022Article
- Cost-Utility Analysis of Screening for Diabetic Retinopathy in China.Health data science · 2022Article
- The Cost-Effectiveness of a Telemedicine Screening Program for Diabetic Retinopathy in New York City.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Validation of an Automated Screening System for Diabetic Retinopathy Operating under Real Clinical Conditions.Journal of clinical medicine · 2021Article
- Telemedicine in cystic fibrosis.Journal of clinical & translational endocrinology · 2021Article
- Telemedicine in diabetic retinopathy screening in India.Indian journal of ophthalmology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine cost-effectiveness and the diagnostic accuracy of teleophthalmology (TO) in the detection of macular edema (ME) and various grades of diabetic retinopathy (DR).
methodsMEDLINE, EMBASE, and Cochrane databases were searched for TO, ME, and DR on May 25, 2016. The search was updated on April 2, 2019. Pooled sensitivity and specificity for ME and various grades of DR were determined using Meta-Disc software. A systematic review of the articles discussing the cost-effectiveness of TO screening was also performed.
resultsThirty-three articles on the diagnostic accuracy and 28 articles on the cost-effectiveness were selected.
conclusionsTelescreening is moderately sensitive but very specific for the diagnosis of diabetic retinopathy. Non-mydriatic Teleretinal screening services are cost-effective, decrease clinics workload, and increase patient compliance if provided free of cost in remote low socioeconomic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.